DERMATA THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DERMATA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $2.25M.
- DERMATA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $4.17M.
- DERMATA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $2.25M, a 26.83% decline from fiscal 2024.
- DERMATA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $3.08M, a 45.48% decline from fiscal 2023.
- DERMATA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $5.65M, a 32.16% increase from fiscal 2022.
- DERMATA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $4.28M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $2.25M 10-K · filed 2026-03-26 | |
| 2025-03-31 | $2.25M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $3.08M 10-K · filed 2026-03-26 | |
| 2023-12-31 | $5.65M 10-K · filed 2025-03-17 | |
| 2023-03-31 | $4.17M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $4.28M 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |